Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Open Access
- 30 November 2000
- journal article
- editorial
- Published by Springer Nature in Trials
- Vol. 1 (3) , 143-145
- https://doi.org/10.1186/cvm-1-3-143
Abstract
The cornerstone in clinical evidence of the relative efficacy of thienopyridines (clopidogrel, ticlopidine) versus aspirin in the secondary prevention of vascular disease is the Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events trial. This trial showed a modest benefit in the reduction of vascular events by clopidogrel. The results differed according to qualifying disorder: myocardial infarction, -3.7%; ischaemic stroke, +7.3%; and peripheral arterial disease, +23.8% (P = 0.042). Similar results were found for ticlopidine after brain ischaemia. The safety of clopidogrel appears to be similar to that of aspirin and better than that of ticlopidine. However, the recent report of thrombotic thrombocytopenic purpura in association with clopidogrel causes concern.Keywords
This publication has 15 references indexed in Scilit:
- Clopidogrel and thrombotic thrombocytopenic purpuraThe Lancet, 2000
- Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in Patients at High Risk of Vascular Disease?Stroke, 2000
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patientsPublished by Wiley ,2000
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Ticlopidine, trials, and torture.Stroke, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989